FDA clears Lupin’s generic ViagraThe erectile dysfunction treatment had a market value of $611 million, according to December 2018 IQVIA data. Wockhardt gets FDA's blessing for generic ZytigaWockhardt's generic of Johnson & Johnson's branded metastatic prostate cancer treatment will be available in a 250-mg dosage strength. Camber unveils generic Cialis Camber's generic Cialis is available in several dosage strengths. Alembic gets FDA OK for generic Optivar Azelastine hydrochloride ophthalmic solution had a market value of roughly $8.5 million for the 12 months ended December 2018, according to IQVIA. Teva launches generic Exjade Exjade had a market value of $134 million for the year ended December 2018, according to IQVIA data. Slayback gets FDA nod for single-dose generic Makena The company previously launched its generic Makena in a 5 ml multidose vial. Perrigo names new CFO Ray Silcock is Perrigo's new executive vice president and CFO, replacing Ronald Winowiecki, who is resigning. Hikma launches Levophed generic Norepinephrine bitartrate injection had a market value of roughly $97 million for the 12 months ended January 2019. Zydus Cadila receives FDA nod for generic Latuda Zydus Cadila's generic Latuda tablets provide a treatment for certain mental/mood disorders. AAM names Karin Hessler assistant general counsel Karin Hessler will focus on Hatch-Waxman, biosimilar and pharmaceutical patent issues. First Previous 178 179 180 181 182 Next Last